{"id":"https://openalex.org/W3134094227","doi":"https://doi.org/10.1200/jco.2021.39.6_suppl.122","title":"Pretherapeutic first-in-human targeting trial of anti-hK2 antibody h11B6: A potential molecular vector for alpha-particle radioimmunotherapy.","display_name":"Pretherapeutic first-in-human targeting trial of anti-hK2 antibody h11B6: A potential molecular vector for alpha-particle radioimmunotherapy.","publication_year":2021,"publication_date":"2021-02-20","ids":{"openalex":"https://openalex.org/W3134094227","doi":"https://doi.org/10.1200/jco.2021.39.6_suppl.122","mag":"3134094227"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2021.39.6_suppl.122","doi":"https://doi.org/10.1200/jco.2021.39.6_suppl.122","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.6_suppl.122","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017288060","display_name":"Michael J. Morris","orcid":"https://orcid.org/0000-0002-9454-0096","observed_orcids":["https://orcid.org/0000-0002-9454-0096"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Morris","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109416521","display_name":"Joseph A. O' Donoghue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph A. O' Donoghue","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054558183","display_name":"Dushen Chetty","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dushen Chetty","raw_affiliation_strings":["Janssen Research & Development, LLC, Spring House, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Spring House, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055268997","display_name":"Steven I. Max","orcid":"https://orcid.org/0009-0005-4710-4776","observed_orcids":["https://orcid.org/0009-0005-4710-4776"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Max","raw_affiliation_strings":["Janssen Research & Development, LLC, Spring House, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Spring House, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044367605","display_name":"Danielle Wanik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125181","display_name":"Invicro (United States)","ror":"https://ror.org/039cbfe54","country_code":"US","type":"company","lineage":["https://openalex.org/I4210125181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danielle Wanik","raw_affiliation_strings":["Invicro LLC, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Invicro LLC, Boston, MA;","institution_ids":["https://openalex.org/I4210125181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041038775","display_name":"Mike R. Russell","orcid":"https://orcid.org/0009-0009-5898-2020","observed_orcids":["https://orcid.org/0009-0009-5898-2020"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mike Russell","raw_affiliation_strings":["Janssen Research & Development, LLC, Spring House, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Spring House, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075938917","display_name":"Tenzin Nyima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tenzin Nyima","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066015282","display_name":"Anjali Narayan Avadhani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anjali Narayan Avadhani","raw_affiliation_strings":["Janssen Research & Development, LLC, Spring House, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Spring House, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066901026","display_name":"Chaitanya R. Divgi","orcid":"https://orcid.org/0000-0002-0146-3678","observed_orcids":["https://orcid.org/0000-0002-0146-3678"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chaitanya R Divgi","raw_affiliation_strings":["Tomopath Inc, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tomopath Inc, Boston, MA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010076893","display_name":"Neeta D. Pandit-Taskar","orcid":"https://orcid.org/0000-0003-1551-2036","observed_orcids":["https://orcid.org/0000-0003-1551-2036"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neeta Pandit-Taskar","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"6_suppl","first_page":"122","last_page":"122"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/humanized-antibody","display_name":"humanized monoclonal antibody","score":0.8759999871253967},{"id":"https://openalex.org/keywords/alpha-particle-radioimmunotherapy","display_name":"alpha particle radioimmunotherapy","score":0.906000018119812},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.8149999976158142},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.7570000290870667},{"id":"https://openalex.org/keywords/salivary-gland-toxicity","display_name":"salivary gland toxicity","score":0.6370000243186951},{"id":"https://openalex.org/keywords/dosimetry","display_name":"dosimetry","score":0.6129999756813049},{"id":"https://openalex.org/keywords/radioligand-therapy","display_name":"radioligand therapy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/alpha-emitters","display_name":"alpha-emitting radionuclides","score":0.5989999771118164}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.837059736251831},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.7886688709259033},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.644885778427124},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5771399736404419},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4582996964454651},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.44122716784477234},{"id":"https://openalex.org/C75088862","wikidata":"https://www.wikidata.org/wiki/Q2291081","display_name":"Dosimetry","level":2,"score":0.41917234659194946},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.41551434993743896},{"id":"https://openalex.org/C67847695","wikidata":"https://www.wikidata.org/wiki/Q626478","display_name":"Radioligand","level":3,"score":0.4131820797920227},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.41211259365081787},{"id":"https://openalex.org/C2779931791","wikidata":"https://www.wikidata.org/wiki/Q161515","display_name":"DOTA","level":3,"score":0.41140297055244446},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3946378827095032},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3669053614139557},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.35935211181640625},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3474305272102356},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3449679911136627},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3325332701206207},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.20654374361038208},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20515170693397522},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2021.39.6_suppl.122","doi":"https://doi.org/10.1200/jco.2021.39.6_suppl.122","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.6_suppl.122","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337415","display_name":"Janssen Research and Development","ror":"https://ror.org/03qd7mz70"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4398233526","https://openalex.org/W3008370538","https://openalex.org/W4281869780","https://openalex.org/W7033329134","https://openalex.org/W2308629042","https://openalex.org/W2298967861","https://openalex.org/W2253980834","https://openalex.org/W4399381283","https://openalex.org/W4391302579","https://openalex.org/W2940075529"],"abstract_inverted_index":{"122":[0],"Background:":[1],"Radioligand":[2],"therapy":[3],"for":[4,141,145,184,193,282],"metastatic":[5],"castration":[6],"resistant":[7],"prostate":[8,17,43],"cancer":[9],"(mCRPC)":[10],"has":[11,270,290],"focused":[12],"to":[13,75,90,163,175,229,246,264],"date":[14],"on":[15],"targeting":[16,245],"specific":[18],"membrane":[19],"antigen,":[20],"an":[21],"approach":[22],"associated":[23],"with":[24,45,105,111,132,208,243],"salivary":[25,221,278],"gland":[26],"toxicity":[27],"and":[28,96,179,211,248,266,276],"variable":[29],"lesion":[30],"expression.":[31],"New":[32],"targets":[33,59,103,261],"are":[34,198],"needed.":[35],"Human":[36],"kallikrein-2":[37],"(hK2)":[38],"is":[39,69,89,256],"overexpressed":[40],"in":[41,61,200,205,217,251],"most":[42],"cancer,":[44],"minimal":[46,106],"normal":[47,185,273],"tissue":[48,268,274],"expression":[49],"or":[50,133],"serum":[51,177],"secretion.":[52],"Humanized":[53],"monoclonal":[54],"antibody":[55],"(mAb)":[56],"h11B6":[57,180,255],"exclusively":[58],"hK2":[60],"pre-clinical":[62],"studies.":[63],"This":[64],"phase":[65,284],"0":[66],"study":[67,287],"(NCT04116164)":[68],"a":[70,98,257,283],"first-in-human":[71],"trial":[72,294],"of":[73,80,85,94,121,214,225,235],"[111In]-DOTA-h11B6":[74,95,124],"determine":[76,97,176],"the":[77,92,194,230,238],"hk2-targeting":[78],"potential":[79],"h11B6.":[81,137],"Objective:":[82],"The":[83],"purpose":[84],"this":[86],"ongoing":[87],"protocol":[88],"characterize":[91],"biodistribution":[93],"suitable":[99],"mAb":[100,259],"mass":[101],"that":[102,260],"mCRPC":[104,113],"non-tumor":[107],"targeting.":[108],"Methods:":[109],"Patients":[110,138],"progressive":[112],"were":[114,139,170],"enrolled.":[115],"A":[116],"single":[117],"slow":[118],"bolus":[119],"infusion":[120],"2":[122,148,173],"mg":[123,136],"(nominally":[125],"185":[126],"MBq":[127],"[111In]),":[128],"was":[129,160,187,203,241],"administered":[130],"IV":[131],"without":[134],"8":[135,164],"observed":[140,242],"adverse":[142],"events":[143],"(AE)":[144],"at":[146,155],"least":[147,156],"weeks.":[149],"Serial":[150,167],"gamma":[151],"camera":[152],"imaging":[153],"including":[154,220],"one":[157],"SPECT/CT":[158],"scan":[159],"performed":[161],"up":[162],"days":[165],"post-administration.":[166],"blood":[168],"samples":[169],"obtained":[171],"over":[172],"weeks":[174],"radioactivity":[178,236],"protein":[181],"levels.":[182],"Dosimetry":[183],"organs":[186],"estimated":[188],"using":[189,288],"OLINDA-EXM.":[190],"Results:":[191],"Results":[192],"first":[195],"6":[196],"patients":[197,207],"summarized":[199],"Table.":[201],"Treatment":[202],"tolerated":[204],"all":[206,252],"no":[209,212,271],"AEs":[210],"evidence":[213],"enhanced":[215],"accumulation":[216],"any":[218],"organ":[219],"glands.":[222,279],"Initial":[223],"volume":[224],"distribution":[226],"appeared":[227],"confined":[228],"vascular":[231,239],"compartment.":[232],"Slow":[233],"clearance":[234],"from":[237],"compartment":[240],"gradual":[244],"skeletal":[247],"non-skeletal":[249],"lesions":[250],"patients.":[253],"Conclusions:":[254],"novel":[258],"hK2,":[262],"localizes":[263],"bone":[265],"soft":[267],"metastases,":[269],"significant":[272],"uptake,":[275],"spares":[277],"An":[280],"IND":[281],"I":[285],"therapeutic":[286],"[225Ac]":[289],"been":[291],"secured.":[292],"Clinical":[293],"information:":[295],"NCT04116164.":[296],"[Table:":[297],"see":[298],"text]":[299]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2021-03-15T00:00:00"}